Type 2 diabetes mellitus (T2DM) represents an emerging
|
|
- Maximillian Earl Miles
- 5 years ago
- Views:
Transcription
1 At Glnce Prcticl Implictio p e102 Author Informtion p e107 Full text nd PDF Web exclusive Potentil Gender Differences of Exentide in Outptients With Type 2 Dibetes Mellitus Originl Reserch Antonio C. Bossi, MD; Ann Pulcin, MD; Eunice O. Ah, MD; Annlis Blini, MD; Denise Berzi, MD; Gincrl Mereglli, MD; nd Giovnni Veronesi, PhD Type 2 dibetes mellitus (T2DM) represents n emerging burden in developing countries nd in developed ntio. In Itly, the prevlence ws 3.9% in 2001, but in 2007 it reched 4.7% n increse of 15% in 6 yers. Itly s ntionl helth system hs to ber the cost of this expeive disese nd its chronic complictio, 1 mong which, crdiovsculr (CV) disese represents the leding cuse of mortlity. Among women with dibetes, neither ll-cuse nor CV disese mortlity declined between 1971 to 1986, nd 1988 to The ll-cuse mortlity rte difference between women with nd without dibetes more thn doubled (from difference of 8.3 to 18.2 nnul deths per 1000 perso). 2 Furthermore, the effects of some clssicl glucose-lowering therpies on CV events re controversil. Twice-dily injectio of exentide, GLP-1 receptor gonist (GLP-1 RA), hve recently become vilble for Itlin ptients with dibetes who did not chieve dequte glycemic control with diet, exercise, nd tretment (ie, monotherpy or combintion tretment with metformin nd sulphonylure, or pioglitzone). Exentide reduces glycted hemoglobin (A1C) nd body weight (BW), with improvement in CV risk fctors in some but not ll ptients. 3 Few dt exist bout gender differences concerning the use of exentide in rel-world settings. STUDY DESIGN AND METHODS We retrospectively studied 69 outptients with type 2 dibetes mellitus (34 mle nd 35 femle; men ge = 52.6 yers [SD = 10.3]; men durtion of dibetes = 9.4 yers [SD = 5.4]) with persistent exentide tretment, nd collected nthropometric (ie, height, BW, body mss index [BMI], wist circumference [WC]), clinicl, nd metbolic prmeters (Tble 1). In ccordnce with the Itlin Phrmcologicl Agency, exentide ws dded to clssicl ntidibetic tretment in order to chieve dequte metbolic control. At bseline, men nd women did not differ substntilly in preexisting therpy. Thirty-two men were on metformin (6 on metformin lone nd 26 in combintion with sulphonylure); nd 2 were on sulphonylure (ie, glyburide ABSTRACT Objectives: Exentide, glucgon-like peptide 1 (GLP-1) receptor gonist, reduces glycted hemoglobin (A1C) nd body weight (BW) nd improves crdiovsculr (CV) risk fctors in some but not ll ptients. This study ws plnned to evlute potentil gender difference of exentide s effects in dibetic subjects. Study Design: A retrospective study compring metbolic control nd chnges in weight, wist circumference, nd body mss index ccording to gender. Methods: We retrospectively collected clinicl dt from 69 outptients with type 2 dibetes mellitus (34 mle nd 35 femle), men ge = 52.6 yers (SD = 10.3); men durtion of dibetes = 9.4 yers (SD = 5.4) with persistent exentide tretment, evluting the evolution of nthropometric, clinicl, nd metbolic prmeters. Results: Exentide rpidly reduced A1C, fsting plsm glucose (FPG), BW, nd wist circumference (WC) in both genders (ll P vlues <.0001). WC ws more reduced in women fter 12 months of tretment (P =.02). After 24 months, ptients showed stble reduction of A1C nd FPG (ll P vlues <.0001 vs bseline) without ny gender-relted difference, while BW lowering ws more pronounced in women compred with men (P =.002). Conclusio: Exentide effected sustined improvement in metbolic nd nthropometric prmeters in both genders, but BW nd WC were more reduced in femles. The women with dibetes experienced more prominent therpeutic benefit for some CV risk fctors nd reduction in wist circumference nd body weight. Am J Phrm Benefits. 2015;7(4):e101-e107 Vol. 7, No. 4 The Americn Journl of Phrmcy Benefits e101
2 n Bossi Pulcin Ah Blini PRACTICAL IMPLICATIONS n Exentide, GLP-1 receptor gonist, reduces glycted hemoglobin (A1C) nd body weight (BW), with improvement in crdiovsculr risk fctors in some, but not ll, ptients with dibetes. This retrospective study evluted potentil gender difference of exentide. n Exentide rpidly reduced A1C nd glycemi in both genders. n Wist girth ws more reduced in women fter 12 months of tretment. After 24 months, BW lowering ws more pronounced in women compred with men. n The women with dibetes experienced more prominent therpeutic benefit from exentide thn men for some CV risk fctors, s well s reduction in wist circumference nd BW. [15], glimepiride [6], gliclzide [5], gliquidone [1], nd repglinide [1]) monotherpy. Thirty-four women were treted with metformin (10 with metformin lone nd 24 in combintion with sulphonylure); nd 1 womn ws on sulphonylure (ie, glyburide [12], glimepiride [6], gliclzide [6], nd repglinide [1]) monotherpy. One womn treted with combintion of metformin nd sulphonylure (glyburide) ws lso in therpy with pioglitzone. Urine nd blood smples were collected in the morning fter 12-hour fst, except for post prndil glucose, which ws collected 2 hours fter lunch; urine nd serum chemistry vlues were determined in our hospitl lbortory with routine methods. Blood pressure (BP) ws mesured with certified sphygmomnometer twice ech visit fter the ptients st for 15 minutes. The men of the 2 mesurements ws recorded. The retrospective study protocol ws pproved by our independent locl ethics committee nd ws conducted in ccordnce with the World Medicl Assocition Declrtion of Helsinki. 4 Sttisticl Anlysis We coidered only ptients with persistent exentide tretment (N = 69); of those, 36 (19 men nd 17 women) reched 2-yer period of follow-up. We did not coider ( priori exclusion) those who bndoned the prescribed exentide therpy, whether for side effects or ny personl or clinicl reson. Metbolic, clinicl, nd nthropometric prmeters were summrized by me of descriptive sttistics for ll the subjects nd by sex. To highlight gender-relted differences t bseline, we dopted t test for independent dt. To describe the vrition over time of given prmeter, we used repeted-mesure model coidering the bseline nd up to 3 follow-up ssessments (month 4, 8, nd 12 from bseline), without specifying ny functionl trend for time. Age nd dibetes durtion were included s covrite into the model. The covrince structure ws compound symmetry; we were not ble to find meningful chnges when more complex models were dopted. In Tble 2, we report the pired t test to ssess whether the chnge from bseline t ny given visit ws different from 0. We then dded sex visit interction term to the model nd tested whether there ws chnge t 12 months from bseline for given prmeter differed by gender. The bovementioned nlysis ws replicted: 1) excluding those with some missing informtion t ny point in time nd 2) dding the 24-month visit for those subjects with 24-month follow-up period (n = 36). All nlyses were conducted using SAS PROC MIXED version softwre (SAS Ititute, Cry, North Crolin). RESULTS nd women showed typicl gender differences in height nd high-deity lipoprotein cholesterol (where HDL-C is generlly higher in women) (Tble 1). BMI nd low-deity lipoprotein cholesterol were both higher in femles with dibetes thn in mles with dibetes (P =.04 nd P =.05, respectively). As shown in Tble 2, exentide rpidly reduced A1C, fsting plsm glucose (FPG), BW, nd WC in both men nd women (ll P <.0001). Systolic nd distolic BP did not significntly chnge fter the first yer of observtion. When coidering gender distribution of A1C, FPG, nd BP, we did not observe ny difference between mles nd femles; however, both BW nd WC were more reduced in women thn in men (Tble 3). Similr findings were obtined when we excluded those subjects with some missing informtion (dt not shown). Furthermore, focusing our ttention on ptients with persistent exentide tretment for 24 months (Figure), we recorded stble nd significnt reductio of A1C nd FPG, with progressive decline of BW ( 4.4 kg, 5.5 kg, 5.9 kg, nd 6.7 kg, respectively, fter 4, 8, 12, nd 24 months; P <.0001 vs bsl vlue t ech time of observtion). Once gin, dichotomizing our ptients by gender, we did not find ny differences in the reduction of A1C nd FPG, lthough BW lowering ws more rpid nd pronounced in women compred with men (Tble 4). DISCUSSION cotitute 51.45% (pproximtely 30 million) of the Itlin popultion. Currently, dibetes is more frequent mong Itlin femles thn mles (5% prevlence vs 4.6%), nd it is estimted tht nerly 3 million Itli e102 The Americn Journl of Phrmcy Benefits July/August 2015
3 Possible Gender Effects of Exentide Tble 1. Clinicl Fetures of Studied Subjects With Dibetes t the Bsl Level Subjects With Dibetes P N Age (yers) 52.6 (10.3) 51.7 (11.0) 53.4 (9.7) Durtion of dibetes (yers) 9.4 (5.4) 10.0 (5.6) 8.8 (5.2) Weight (kg) (21.3) (23.2) (18.7) Height (cm) (9.7) (6.7) (6.5) <.0001 BMI 38.2 (7.3) 36.4 (7.5) 40.0 (6.7).04 Wist circumference (cm) (12.1) (13.1) (11.3) SBP (mm HG) (17.0) (18.0) (16.3) DBP (mm HG) 80.2 (7.8) 79.7 (8.9) 80.7 (6.8) A1C (%) 9.4 (1.3) 9.4 (1.2) 9.5 (1.4) (mmol/mol) 79 (11.9) 79 (10.8) 108 (13) FPG (mg/dl) (52.1) (58.6) (43.9) (mmol/l) (2.87) (3.22) (2.41) Post prndil glucose (mg/dl) (59.7) (57.9) (61.9) (mmol/l) (3.28) (3.19) 10.6 (3.41) Microlbuminuri (mg/l) 54.8 (141.7) 57.1 (159.5) 52.2 (121.9) Totl cholesterol (mg/dl) (37.2) (35.4) (38.5) (mmol/l) 4.97 (0.96) 4.80 (0.91) 5.14 (0.99) HDL-C b (mg/dl) 43.5 (12.2) 39.6 (8.9) 47.6 (13.9) (mmol/l) 1.12 (0.31) 1.02 (0.23) 1.23 (0.35).007 LDL-C b (mg/dl) (30.4) (33.2) (25.5) (mmol/l) 2.81 (0.78) 2.61 (0.85) 3.02 (0.65).05 Triglycerides (mg/dl) (147.7) (82.0) (195.1) (mmol/l) 2.42 (1.68) 2.44 (0.93) 2.39 (2.22) BMI indictes body mss index; DBP, distolic blood pressure; FPG, fsting plsm glucose; HDL-C, high-deity lipoprotein cholesterol; LDL-C, low-deity lipoprotein cholesterol;, not significnt; SBP, systolic blood pressure. Dt vilble for 57 subjects (30 men, 27 women). b Dt vilble for 54 subjects (27 men, 27 women). Dt re expressed s men ± SD. The P vlue is testing the difference between men nd women (noignificnt = P >.05). suffer from this metbolic disese. 5 The prevlence of T2DM increses proportionlly with ge, nd the difference in life expectncy my ccount for the different prevlence of dibetes between genders, with the verge lifespn being 6 yers longer in women thn in men. Furthermore, CV disese is the leding cuse of deth mong women in Itly, with >40% of deths ttributed to this disese, nd ccounting for 50% of deths in femles 65 yers or older. For this reson, conditio in women require prticulr ttention s fr s both prevention nd therpy re concerned. Gender differences my lso be relevnt in the mngement of T2DM, s dt from the Dibetes Prevention Progrm showed some sex-specific differences, 6 while other popultion trils hve underlined the differences between men nd women in the effects of vrious CV risk fctors. 7,8 Additionlly, the reltive risk of ftl coronry hert disese ssocited with dibetes ws found to be 50% higher in women thn in men. 9 In study of outptients with dibetes, 3 women with T2DM hd worse CV risk profile nd chieved therpeutic gols less frequently thn did men. Add-on therpy with exentide my provide n dvntge, s suggested by some studies 10,11 in which djunctive exentide tretment resulted in sustined improvement in glucose metbolism nd nthropometric prmeters, s well s in CV risk fctors. In our study, we observed uniform reduction of A1C nd decrese of FPG in the group treted with exentide, even if not t levels reching the desired therpeutic trgets (Tble 2; Figure). However, the observed A1C reduction ws even better thn tht recorded by the Itlin report on new ntidibetic drugs (Δ = 0.93%). 12 Although we cnnot exclude tht our findings could t lest in prt be explined by lifestyle differences, gender-relted psychologicl/body imge issues, nd the Vol. 7, No. 4 The Americn Journl of Phrmcy Benefits e103
4 n Bossi Pulcin Ah Blini Tble 2. Evolution of Min Clinicl Prmeters 4, 8, nd 12 Months After Exentide Add-on Tretment Bsl After 4 Months After 8 Months After 12 Months Vlue N Difference N Difference N Difference A1C (%) b 1.5 b 1.6 b (mmol/mol) b 14 b 15.1 b FPG (mg/dl) b 43.6 b 46.5 b (mmol/l) b 2.40 b 2.56 b Weight (kg) b b b Wist circumference (cm) b b b SBP (mm Hg) DBP (mm Hg) A1C indictes glycted hemoglobin; DBP, distolic blood pressure; FPG, fsting plsm glucose; N, number of nonmissing observtio; SBP, systolic blood pressure. Averge difference between bseline vlue nd every follow-up ssessment, t 4, 8, nd 12 months fter the beginning of the tretment with exentide. b Difference test = 0; t test for pired dt; P < fct tht femles with dibetes hd significntly higher BMIs t bseline compred with the mle ptients, we observed tht BW nd WC reductio were more pronounced in women thn in men fter 12 months of exentide tretment (Tble 3). Our ptients showed reduction of BW with significnt gender difference ( 7.6 kg in women nd 3.4 kg in men; P =.0001) (Tble 2); women lso hd greter reduction of wistline ( 6.5 cm) in comprison with men ( 3.6 cm; P =.02) (Tble 3). In those completing 24 months of tretment, we did not record ny significnt gender difference in the reduction of A1C or of FPG (Figure; Tble 4). However, on weight mesures, femles showed reduction of 8.7 kg versus 3.7 kg in men (P =.002) (Tble 4). Our rel-world dt, while confirming the cceptble glycemic efficcy of exentide in both sexes, demotrted better nthropometric respoe in women with dibetes. A recent retrospective met-nlysis of 16 studies, including 2067 ptients with dibetes treted with exentide, did not show ny gender difference regrding glycemic control, lthough the observed weight loss ws significntly higher in femles thn in mles. 13 To potentilly explin the observed gender difference in our ptients, it ws suggested tht in norml-weight individuls, the elicited secretion of endogenous GLP-1 by me of fiber-rich nutrients is greter in women. 14 Phrmcologiclly, possible interference with previous clssic ntidibetic tretment ppers unlikely, becuse similr proportio of men nd women were treted with metformin s monotherpy, nd metformin nd sulphonylure in combintion. Moreover, t the end of the observtion (24-month completers), we registered the suspeion of sulphonylure in 6 men nd in 6 women, nd sulphonylure dose-reduction in 9 men nd in 2 women; however, men demotrted no dvntge of this reduction in terms of mjor decrese in BW. We did not dd exentide to iulin-treted T2DM ptients becuse of specific contrindiction defined by the Itlin regultory system. However, the ddition of GLP-1 nlogues to iulin in ptients with T2DM should be ssocited with reduction in A1C, BW, nd iulin dose, long with low risk of hypoglycemi nd high tretment stisfction, s reported by recent Swedish study. 15 According to efficcy-bsed guidelines for prevention of CV disese in femles, weight mngement (mong other recommendtio) hs to be implemented for ll women, becuse obesity is one of the most importnt risk fctors for developing T2DM, nd becuse the presence of dibetes increses womn s risk for CV disese. 16 GLP-1 RAs (eg, exentide twice dily, exentide once week, lirglutide, lixisentide) nd dipeptidyl peptidse-4 (DPP-4) inhibitors (eg, sitgliptin, vildgliptin, sxgliptin, lingliptin, logliptin), presently vilble in Itly, re new drugs tht cn significntly reduce A1C if given in monotherpy or in combintion with other ntidibetic drugs. These incretin-bsed therpies hve very low risk for the development of hypoglycemi, nd either decrese BW (GLP-1 nlogues) or hve neutrl effect on it (DPP-4 inhibitors). 17 The low risk of hypoglycemi is very importnt dvntge becuse, ccording to the Action to Control Crdiovsculr Risk in Dibetes (ACCORD) Study, 18 higher mortlity is ssocited with hypoglycemi in both inteive glycemic nd conventionl tretment rms. Therefore, when there is need to inteify glucose control, hypoglycemi my increse CV risk nd counter the benefits of reducing hyperglycemi. Moreover, incretin drugs offer coiderble promise s me of trgeting the primry defect in T2DM: exentide (nd other GLP-1 RAs) exert positive beneficil effects on the β-cells, thereby limiting the disese progression nd e104 The Americn Journl of Phrmcy Benefits July/August 2015
5 Possible Gender Effects of Exentide Tble 3. Gender Evolution of Clinicl Prmeters After 12 Months Bsl Δ After 12 Months Bsl Δ After 12 Months P A1C (%) (mmol/mol) FPG (mg/dl) (mmol/l) Weight (kg) Wist circumference (cm) SBP (mmhg) DBP (mmhg) A1C indictes glycted hemoglobin; Δ (delt), difference; DBP, distolic blood pressure; FPG, fsting plsm glucose; SBP, systolic blood pressure. P difference test: the nlysis performed to ssess potentil sttisticl difference between men nd women of the observed vrition during time of the interested prmeters (djusted for ge nd durtion of dibetes). Evolution expressed s Δ: the verge difference from bsl vlues. the development of its complictio. 19 Furthermore, exentide improved glycemic control, reduced BW, nd ws ssocited with lower risk of CV events in comprison with other hypoglycemic gents. 20 In recent observtion from nother Itlin group, 21 trget glycemic respoe ws chieved in significntly higher proportion of mles thn femles, while trget weight loss rbitrrily expressed s 1-yer percent loss 75th percentile in the whole popultion (8.5%) ws more often chieved mong femles t 8 months (28% vs 15%; χ 2 = 8.04; P =.004) nd 12 months (33% vs 17%; χ 2 = 10.98; P =.0009). After substituting body weight with BMI, the results did not chnge. These observtio highlight gender difference in the nthropometric evolution during exentide tretment. We observed similr A1C evolution in both genders with dibetes, with more fvorble reduction in BW nd WC in women, confirming the observtion of the Itlin group 21 nd tht in the nlysis by Pencek nd collegues, 13 in which the finl weight loss observed in ptients ws likewise significntly higher in femles thn in mles. However, lthough the evolution of glycemic control nd BW loss fter 12 months of exentide therpy should be predicted Figure. Evolution of Some Clinicl Prmeters in 36 Ptients Tht Reched 2-Yer Period of Follow-up A1C Fsting Plsm Glucose Weight A1C (%) All subjects Fsting Plsm Glucose (mg/dl) All subjects Weight (kg) All subjects Months From Bseline Months From Bseline Months From Bseline A1C indictes glycted hemoglobin. The 36 ptient were comprised of 19 men nd 17 women. A1C (%), fsting plsm glucose (mg/dl), nd body weight (kg) fter 4, 8, 12, nd 24 months of persistent tretment with exentide. Difference test = 0; t test for pired dt; P <.0001 for ll subjects in comprison with bseline levels, t every period of observtion (4, 8, 12, nd 24 months). Vol. 7, No. 4 The Americn Journl of Phrmcy Benefits e105
6 n Bossi Pulcin Ah Blini Tble 4. Gender Evolution of Some Clinicl Prmeters After 4, 12, nd 24 Months in 36 Ptients With Complete 2-Yer Follow-up Period Vlue Δ From Bsl Vlue Vlue Δ From Bsl Vlue P b A1C % (mmol/mol) Bsl 9.2 (77) 9.4 (79) 4 months 7.7 (61) 1.5 ( 16) 7.8 (62) 1.6 ( 17) 12 months 7.8 (62) 1.4 ( 15) 7.5 (61) 1.9 ( 18) 24 months 7.7 (61) 1.5 ( 16) 7.6 (60) 1.8 ( 19) FPG mg/dl Bsl (11.76) months (9.28) 44.9 ( 2.47) ( 2.47) 12 months (9.13) 47.7 ( 2.62) ( 2.62) 24 months (9.0) 50.1 ( 2.76) ( 2.45) Weight (kg) Bsl months months months A1C indictes glycted hemoglobin; Δ (delt), difference; FPG, fsting plsm glucose;, not significnt. The 36 ptient were comprised of 19 men nd 17 women. b P difference test: the nlysis performed to ssess potentil sttisticl difference between men nd women of the observed vrition during time of the interested prmeters (djusted for ge nd durtion of dibetes). Evolution expressed s Δ: the verge difference from bseline. in different wys between genders in T2DM, 21 the intriic mechnisms of weight loss obtined with GLP-1 receptor gonists re not fully understood. The higher men BMI observed in women (Tble 1) my hve contributed to greter weight loss fter exentide, but this difference is not reported in the popultion of Anichini nd collegues. 21 Moreover, GLP-1 RAs decrese the rte of gstric emptying, reduce ppetite, nd promote stiety, but they my lso provide chnges in energy expenditure nd in leptin seitivity, or cuse nuse resulting in decresed food intke fctors ll leding to dipose tissue reduction. Ltely, short-term exentide tretment hs been ssocited with modest weight loss nd decresed WC in cohort of obese nondibetic women. 22 Recent dt suggest tht, during mel, GLP-1 cn simultneously exert n incretin effect on iulin secretion nd protective effect on endothelil function, resonbly controlling oxidtive stress genertion. 23 The prospect of CV protection in ptients treted with exentide is very encourging becuse these ptients usully hve other comorbidities in ddition to T2DM. ctully hve fewer bsl risk fctors thn men, but ccording to n Itlin report, they re more sedentry nd re dignosed to hve dibetes 3 yers lter thn men. 24 Furthermore, recent study reports tht women re more obese thn men t the time of dignosis of dibetes. 25 So, we my hypothesize tht femles should revel greter seitivity to reducing weight fter exentide therpy. Limittio nd Strengths There re severl limittio of this study, primrily the smll number of studied subjects nd the inclusion of only completers in the nlysis. Another limittion is the study s retrospective observtionl design nd the lck of control group. Possible confounding fctors to be coidered in the results evlution re incresed physicl ctivity or chnges in eting hbits due to initil fvorble results obtined with the novel therpy, which could prtilly explin the noted effects. Generl side effects such s nuse nd vomiting were not studied in detil since we coidered only ptients with persistent exentide tretment; those who bndoned the prescribed therpy were excluded priori. Moreover, we were not ble to record hypoglycemic events, once gin becuse of the retrospective design of the study. On the other hnd, in our rel-world study popultion, we did not observe ny mjor dverse event such s pncretitis or pncretic cncer. A strength of the study is the quite long period of observtion, nd the opportunity to strtify our ptients by gender, prtilly confirming nd reinforcing previous e106 The Americn Journl of Phrmcy Benefits July/August 2015
7 Possible Gender Effects of Exentide observtio. 13,21 Finlly, it is to be coidered tht this investigtion took clinicl settings into ccount; new incretin-bsed therpies cnnot, however, be detched from lifestyle modifiction. Preventing CV disese is fundmentl in both sexes, especilly in women who tend to be less physiclly ctive thn men. The most dngerous risk fctor for women, in Itly, is not coidering CV disese s pthology prticulrly relevnt to femles. Tretment strtegies should be improved in both sexes, but women with dibetes should receive more ggressive therpy, especilly when CV complictio re present. CONCLUSIONS Persistent exentide tretment s dd-on therpy in T2DM my show gender difference in terms of clinicl results. In our clinicl prctice, s result of the study, we suggest exentide s the drug of choice in obese or overweight ptients suffering from T2DM, with the likelihood tht women with dibetes should experience more prominent therpeutic effect (in comprison with men) on some of their CV risk fctors but, due to the observtionl retrospective design of the present study, ny suggested gender difference during tretment with GLP-1 RAs needs confirmtion by trils designed specificlly to ddress this topic. Author Affilitio: Metbolic Diseses nd Dibetes Unit, Treviglio-Crvggio Hospitl (ACB, AP, AB, DB, GM), Treviglio, Itly; Komfo Anokye Teching Hospitl (EOA), Kumsi, Republic of Ghn; Iubri University of Studies, EPIMED Reserch Center (GV), Vrese, Itly. Funding Source: None. Author Disclosures: Dr Bossi received reserch grnts from Eli Lilly, Novo Nordisk, nd coultnt/dvisor honorri from Johon & Johon nd Boehringer Ingelheim. Dr Blini obtined spoorship from Eli Lilly, nd reserch grnts from Novo Nordisk. Dr Berzi received spoorship from Snofi-ventis nd Eli Lilly. Drs Mereglli nd Veronesi obtined spoorship from Eli Lilly. Drs Pulcin nd Ah report no reltiohip or finncil interest with ny entity tht would pose conflict of interest with the subject mtter of this rticle. Authorship Informtion: Concept nd design (ACB); cquisition of dt (ACB, AP, AB, DB, GM); nlysis nd interprettion of dt (ACB, EOA, AP, AB, DB, GM, GV); drfting of the mnuscript (ACB, EOA); criticl revision of the mnuscript for importnt intellectul content (ACB, GV); sttisticl nlysis (GV); nd supervision (ACB). Send correspondence to: Antonio C. Bossi, MD, Metbolic Diseses nd Dibetes Unit Treviglio-Crvggio Hospitl, P.le Ospedle, Treviglio (BG), Itly. E-mil: ntonio_bossi@ospedle.treviglio.bg.it. REFERENCES 1. Lucioni C, Grncini MP, Mssi-Benedetti M, Mzzi S, Serr G; CODE-2 Itlin Advisory Bord. The costs of type 2 dibetes mellitus in Itly: CODE-2 sub-study. Tret Endocrinol. 2003;2(2): Gregg EW, Gu Q, Cheng YJ, Nryn KM, Cowie CC. Mortlity trends in men nd women with dibetes, Ann Intern Med. 2007;147(3): Klonoff DC, Buse JB, Nielsen LL, et l. Exentide effects on dibetes, obesity, crdiovsculr risk fctors nd heptic biomrkers in ptients with type 2 dibetes treted for t lest 3 yers. Curr Med Res Opin. 2008;24(1): Declrtion of Helsinki: Ethicl Principles for Medicl Reserch Involving Humn Subjects (2008 revision). World Medicl Assocition website. wm.net/en/30publictio/10policies/b3/17c.pdf. Published Accessed September 19, Annurio Istt 2009: snità e slute in Itli. Centro Nzionle di Epidemiologi, Sorveglinz e Promozione dell Slute website. politiche_snitrie/nnurio_istt_09.sp [Itlin]. Published Accessed September 19, Perreult L, M Y, Dgogo-Jck S, et l; Dibetes Prevention Progrm. Sex differences in dibetes risk nd the effect of inteive lifestyle modifiction in the Dibetes Prevention Progrm. Dibetes Cre. 2008;31(7): Howrd BV, Cown LD, Go O, Welty TK, Robbi DC, Lee ET. Adverse effects of dibetes on multiple crdiovsculr disese risk fctors in women: the Strong Hert Study. Dibetes Cre. 1998;21(8): Ridker PM, Rifi N, Rose L, Buring JE, Cook NR. Comprison of C-rective protein nd low-deity lipoprotein cholesterol levels in the prediction of first crdiovsculr events. N Engl J Med. 2002;347(20): Huxley R, Brzi F, Woodwrd M. Excess risk of ftl coronry hert disese ssocited with dibetes in men nd women: met-nlysis of 37 prospective cohort studies. BMJ. 2006;332(7533): Buysschert M, Preumont V, Oriot PR, et l; UCL Study Group for Exentide. One-yer metbolic outcomes in ptients with type 2 dibetes treted with exentide in routine prctice. Dibetes Metb. 2010;36(5): Kutzky-Willer A, Kmyr MR, Gerht D, et l. Sex-specific differences in metbolic control, crdiovsculr risk, nd interventio in ptients with type 2 dibetes mellitus. Gend Med. 2010;7(6): Registro frmci ntidibetici sottoposti monitorggio. Rpporto frmci incretino-mimetici e DPP-4 inibitori [Itlin report]. Rome, Itly: AIFA; Pencek R, Blickederfer A, Li Y, Brunell SC, Anderson PW. Exentide twice dily: nlysis of effectiveness nd sfety dt strtified by ge, sex, rce, durtion of dibetes, nd body mss index. Postgrd Med. 2012;124(4): Adm TC, Westerterp-Plnteng MS. Nutrient-stimulted GLP-1 relese in norml-weight men nd women. Horm Metb Res. 2005; 37(2): Lind M, Jendle J, Torffvit O, Lger I. Glucgon-like peptide 1 (GLP-1) nlogue combined with iulin reduces HbA1c nd weight with low risk of hypoglycemi nd high tretment stisfction. Prim Cre Dibetes. 2012;6(1): Mosc L, Benjmin EJ, Berr K, et l. Effectiveness-bsed guidelines for the prevention of crdiovsculr disese in women 2011 updte: guideline from the Americn Hert Assocition. Circultion. 2011;123(11): Grber AL. Incretin-bsed therpies in the mngement of type 2 dibetes: rtionle nd relity in mnged cre setting. Am J Mng Cre. 2010;16(7 suppl):s187-s ACCORD Study Group; Gerstein HC, Miller ME, Genuth S, et l. Long-term effects of inteive glucose lowering on crdiovsculr outcomes. N Engl J Med. 2011;364(9): Holst JJ, Knop FK, Visbøll T, Krrup T, Mdsbd S. Loss of incretin effect is specific, importnt, nd erly chrcteristic of type 2 dibetes. Dibetes Cre. 2011;34(2 suppl):s251-s Best JH, Hoogwerf BJ, Hermn WH, et l. Risk of crdiovsculr disese events in ptients with type 2 dibetes prescribed the glucgon-like peptide 1 (GLP1) receptor gonist exentide twice dily or other glucose-lowering therpies: retrospective nlysis of the LifeLink dtbse. Dibetes Cre. 2011;34(1): R. Anichini, S. Cosimi, A. Di Crlo et l. Gender difference in respoe predictors fter 1-yer exentide therpy twice dily in type 2 dibetic ptients: rel world experience. Dibetes Metb Syndr Obes. 2013;6: Dushy J, Go C, Goplkrishnn GS, et l. Short-term exentide tretment leds to significnt weight loss in subset of obese women without dibetes. Dibetes Cre. 2012;35(1): Ceriello A, Esposito K, Test R, Bonfigli AR, Mrr M, Giuglino D. The possible protective role of glucgon-like peptide 1 on endothelium during the mel nd evidence for n endothelil resistnce to glucgon-like peptide 1 in dibetes. Dibetes Cre. 2011;34(3): Simon Gimpoli. Istituto Superiore di Snità Rom. Obesità, stili di vit e rischio crdiovscolre. Itlin Ministry of Helth website. imgs/c_17_newsaree_1092_listfile_itemnme_12_file.pdf [Itlin]. Published Accessed September 19, Wnnmethee SG, Ppcost O, Lwlor DA, et l. Do women exhibit greter differences in estblished nd novel risk fctors between dibetes nd non-dibetes thn men? the British Regionl Hert Study nd British s Hert Helth Study. Dibetologi. 2012;55(1): Vol. 7, No. 4 The Americn Journl of Phrmcy Benefits e107
Effect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationEffects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
Originl Article Others Dibetes Metb J 215;39:335-341 http://dx.doi.org/1.493/dmj.215.39.4.335 pissn 2233-679 eissn 2233-687 DIABETES & METABOLISM JOURNAL Effects of 6-Month Sitgliptin Tretment on Insulin
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationEffects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study
Originl Article Clinicl Cre/Eduction Dibetes Metb J 20;3:34-3 http://dx.doi.org/.403/dmj.20.3..34 pissn 2233-0 eissn 2233-0 D I A B E T E S & M E T A B O L I S M J O U R N A L Effects of -Month Exentide
More informationFat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
Originl ppers Ft intke in ptients newly dignosed with type 2 dibetes: 4-yer follow-up study in generl prctice Floris A vn de Lr, Eloy H vn de Lisdonk, Peter L B J Lucssen, J M H Tigchelr, Sski Meyboom,
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationThe Acute Time Course of Concurrent Activation Potentiation
Mrquette University e-publictions@mrquette Exercise Science Fculty Reserch nd Publictions Exercise Science, Deprtment of 1-1-2010 The Acute Time Course of Concurrent Activtion Potentition Luke Grceu Mrquette
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationAnalysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia
284 Anlysis of lterntives for izing ptients to chieve glycemic control nd void ccompnying risks of hypoglycemi JIALIN GAO 1,2*, QIANYIN XIONG 1,2*, JUN MIAO 1*, YAO ZHANG 2,3, LIBING XIA 1, MEIQIN LU 1,
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationOriginal Article INTRODUCTION. Korean Diabetes J 2010;34: doi: /kdj pissn eissn
Originl Article doi: 1.493/kdj.21.34.6.34 pissn 1976-918 eissn 293-265 The Smll Rice Bowl-Bsed Mel Pln ws Effective t Reducing Dietry Energy Intke, Body Weight, nd Blood Glucose Levels in Koren Women with
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationIn the treatment of cardiovascular disease (CVD), national
n report n Beyond LDL Cholesterol: The Role of Elevted Triglycerides nd Low HDL Cholesterol in Residul CVD Risk Remining After Sttin Therpy Peter Algon Jr, MD, FACC In the tretment of crdiovsculr disese
More informationOriginal Article. Diabetes Metab J 2011;35:26-33 doi: /dmj pissn eissn
Originl Article Dibetes Metb J 211;35:26-33 doi: 1.493/dmj.211.35.1.26 pissn 2233-679 eissn 2233-687 D I A B E T E S & M E T A B O L I S M J O U R N A L Comprison of the Efficcy of Glimepiride, Metformin,
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationobesità nel bambino: epidemiologia e prevenzione
Obesità, Nutrizione e Stili di vit. Trento 31 Mrzo 27 obesità nel bmbino: epidemiologi e prevenzione Cludio Mffeis Diprtimento Mterno Infntile e Biologi-Genetic Sezione di Peditri - Università di Veron
More informationSee 17 for PATIENT COUNSELING INFORMATION and FDAapproved patient labeling. Revised: 6/2016 FULL PRESCRIBING INFORMATION: CONTENTS*
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use BASAGLAR sfely nd effectively. See full prescribing informtion for BASAGLAR BASAGLAR (insulin glrgine
More informationDivision of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 2
Originl Article Epidemiology http://dx.doi.org/1.493/dmj.214.38.1.51 pissn 2233-679 eissn 2233-687 DIABETES & METABOLISM JOURNAL Higher Prevlence nd Awreness, but Lower Control Rte of Hypertension in Ptients
More informationClinical statistics analysis on the characteristics of pneumoconiosis of Chinese miner population
Originl Article Clinicl sttistics nlysis on the chrcteristics of pneumoconiosis of Chinese miner popultion Mei-Fng Wng 1 *, Run-Ze Li 2 *, Ying Li 2, Xue-Qin Cheng 1, Jun Yng 1, Wen Chen 3, Xing-Xing Fn
More informationY. Yazici 1, D. Moniz Reed 2, C. Klem 2, L. Rosenblatt 2, G. Wu 2, J.M. Kremer 3
Greter remission rtes in ptients with erly versus long-stnding disese in biologic-nive rheumtoid rthritis ptients treted with btcept: post hoc nlysis of rndomised clinicl tril dt Y. Yzici 1, D. Moniz Reed
More informationReport of the Conference on Low Blood
1046 Report of the Conference on Low Blood Cholesterol: Mortlity Associtions Dvid Jcobs, PhD; Henry Blckburn, MD; Millicent Higgins, MD; Dwyne Reed, MD, PhD; Hiroysu Iso, MD; Grdner McMilln, MD, PhD; Jmes
More informationDepartment of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, 3
Originl Article Clinicl Cre/Eduction Dibetes Metb J 2015;39:489-497 http://dx.doi.org/10.4093/dmj.2015.39.6.489 pissn 2233-6079 eissn 2233-6087 DIABETES & METABOLISM JOURNAL Clinicl Chrcteristics nd Metbolic
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationLow Fasting Triglycerides: Hallmark of the Healthy Large Hip?
nture publishing group rticles Low Fsting Triglycerides: Hllmrk of the Helthy Lrge Hip? Johnnes B. Ruige 1 nd Luc F. Vn Gl 2 Body ft distribution modultes risk for type 2 dibetes mellitus. We evluted potentilly
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationSummary. Effect evaluation of the Rehabilitation of Drug-Addicted Offenders Act (SOV)
Summry Effect evlution of the Rehbilittion of Drug-Addicted Offenders Act (SOV) The Rehbilittion of Drug-Addicted Offenders Act (SOV) ws lunched on April first 2001. This lw permitted the compulsory plcement
More informationComparison of three simple methods for the
J. clin. Pth. (1967), 2, 5 Comprison of three simple methods for the ssessment of 'free' thyroid hormone T. M. D. GIMLETTE1 From the Rdio-Isotope Lbortory, St. Thoms's Hospitl, London SYNOPSIS A dilysis
More informationOriginal Paper. Med Princ Pract 2017;26: DOI: /
Originl Pper Med Princ Prct 2017;26:146 151 Received: Mrch 28, 2016 Accepted: December 6, 2016 Published online: December 6, 2016 The Assocition of Vitmin D Sttus nd Vitmin D Replcement Therpy with Glycemic
More informationGeographical influence on digit ratio (2D:4D): a case study of Andoni and Ikwerre ethnic groups in Niger delta, Nigeria.
Journl of Applied Biosciences 27: 1736-1741 ISSN 1997 5902 Geogrphicl influence on digit rtio (2D:4D): cse study of Andoni nd Ikwerre ethnic groups in Niger delt, Nigeri. Gwunirem, Isrel U 1 nd Ihemelndu,
More informationTarget: 10 mg/day within several days Schizophrenia in adolescents (2.1)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use ZYPREXA sfely nd effectively. See full prescribing informtion for ZYPREXA. ZYPREXA (olnzpine) Tblet
More informationInfluence of the Duration of Diabetes on the Outcome of a Diabetes Self-Management Education Program
Originl Article Clinicl Cre/Eduction http://dx.doi.org/10.4093/dmj.2012.36.3.222 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Influence of the Durtion of Dibetes
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationSmall Rice Bowl-Based Meal Plan for Energy and Marcronutrient Intake in Korean Men with Type 2 Diabetes: A Pilot Study
Originl Article doi: 1.493/dmj.11.35.3.73 pissn 33-679 eissn 33-687 D I A B E T E S & M E T A B O L I S M J O U R N A L Smll Rice Bowl-Bsed Mel Pln for Energy nd Mrcronutrient Intke in Koren Men with Type
More informationA series of recent studies and meta-analyses confirm
Originl Reserch Clinicl Medicine & Reserch Volume 11, Number 4: 210-218 2013 Mrshfield Clinic clinmedres.org Brest nd Prostte Cncer Survivors in Dibetic Cohort: Results from the Living With Dibetes Study
More informationOriginal Investigation. management of type 2 diabetes mellitus.
Reserch Originl Investigtion Roux-en-Y Gstric Bypss Surgery or Lifestyle With Intensive Medicl Mngement in Ptients With Type 2 Dibetes Fesibility nd 1-Yer Results of Rndomized Clinicl Tril Florenci Hlperin,
More informationThe Quality and Outcomes Framework (QOF) is a pay-for-performance
Effect of UK Py-for-Performnce Progrm on Ethnic Disprities in Dibetes Outcomes: Interrupted Time Series Anlysis Riydh Alshmsn, MSc John Tyu Lee, MSc Azeem Mjeed, MD Goplkrishnn Netuveli, PhD Christopher
More informationThe Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
Originl Article Clinicl Cre/Eduction Dibetes Metb J 214;38:211-219 http://dx.doi.org/1.493/dmj.214.38.3.211 pissn 2233-679 eissn 2233-687 DIABETES & METABOLISM JOURNAL The Effect of DPP-4 Inhibitors on
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationOriginal Article Clinical Care/Education INTRODUCTION DIABETES & METABOLISM JOURNAL
Originl Article Clinicl Cre/Eduction Dibetes Metb J 216;4:454-462 https://doi.org/.493/dmj.216.4.6.454 pissn 2233-679 eissn 2233-687 DIABETES & METABOLISM JOURNAL Reduction of Sulfonylure with the Initition
More informationEstimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain
Rpid communictions Estimting the impct of the influenz pndemic on mortlity in the elderly in Nvrre, Spin J Cstill (jcstilc@nvrr.es) 1, J Etxeberri 1, E Ardnz 1, Y Floristán 1, R López Escudero 1, M Guevr
More informationShamsuddin M. Mamun, U. Focken, G. Francis and K. Becker University of Hohenheim, Stuttgart, Germany. September 2004
A GROWTH PERFORMANCE AND METABOLIC RATES OF GENETICALLY IMPROVED AND CONVENTIONAL STRAINS OF NILE TILAPIA, OREOCHROMIS NILOTICUS (L.) Shmsuddin M. Mmun, U. Focken, G. Frncis nd K. Becker University of
More informationkey words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization
reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,
More informationThe potential future of targeted radionuclide therapy: implications for occupational exposure? P. Covens
The potentil future of trgeted rdionuclide therpy: implictions for occuptionl exposure? Introduction: Trgeted Rdionuclide Therpy (TRT) Systemic tretment Molecule lbelled with rdionuclide delivers toxic
More informationThe Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
Originl Article Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.2.125 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L The Reltionship between Metformin nd Cncer in
More informationEffects of Weight Reduction on Serum Vaspin Concentrations in Obese Subjects: Modification by Insulin Resistance
nture publishing group rticles Effects of Weight Reduction on Serum Vspin Concentrtions in Obese Subjects: Modifiction by Insulin Resistnce Hye M. Chng 1, He J. Lee 1, Hye S. Prk 1, Je H. Kng 2, Kyung
More informationRisk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort
Specil Report Risk of Colorectl Cncer by Subsite in Swedish Prostte Cncer Cohort Yunxi Lu, MD, PhD, Rickrd Ljung, MD, PhD, Ann Mrtling, MD, PhD, nd Mts Lindbld, MD, PhD Bckground: The reltionship between
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More informationInhaled Corticosteroid Is Associated With an Increased Risk of TB in Patients With COPD
CHEST Originl Reserch Inhled Corticosteroid Is Associted With n Incresed Risk of TB in Ptients With COPD Jung-Hyun Kim, MD ; Ji-Soo Prk, MD ; Kyung-Ho Kim, MD ; Hye-Cheol Jeong, MD ; Eun-Kyung Kim, MD
More informationProstate cancer is among the most common malignancies
Implictions of Evolving Delivery System Reforms for Prostte Cncer Cre Brent K. Hollenbeck, MD, MS; Mggie J. Bierlein, MS; Smuel R. Kufmn, MS; Lindsey Herrel, MD; Ted A. Skolrus, MD, MPH; Dvid C. Miller,
More informationAddendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)
Addendum to the Evidence Review Group Report on Aripiprzole for the tretment of schizophreni in dolescents (ged 15-17 yers) Produced by Authors Correspondence to Southmpton Helth Technology Assessments
More informationRelationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients
J Renl Inj Prev. 2017; 6(2): 88-92. http://journlrip.com Journl of Renl Injury Prevention DOI: 10.15171/jrip.2017.17 Reltionship between serum irisin, glycemic indices, nd renl function in type 2 dibetic
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationDiabetes is a chronic and highly prevalent condition that
Mediction Adherence nd Improved Outcomes Among Ptients With Type 2 Dibetes Srh E. Curtis, MPH; Kristin S. Boye, PhD; Mureen J. Lge, PhD; nd Luis-Emilio Grci-Perez, MD, PhD Dibetes is chronic nd highly
More informationA Comparative Study of Eating Habits and Food Intake in Women with Gestational Diabetes according to Early Postpartum Glucose Tolerance Status
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.4.354 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L A Comprtive Study of Eting Hbits nd Food Intke in Women with
More informationUtility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension
Originl Article Endocrinol Metb 2017;32:221-229 https://doi.org/10.3803/enm.2017.32.2.221 pissn 2093-596X eissn 2093-5978 Utility of the Viscerl Adiposity Index nd Hypertriglyceridemic Wist Phenotype for
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More informationWork-related musculoskeletal disorders (WMSDs) among nursing personnel
Work-Relted Musculoskeletl Injuries nd Disorders Among Occuptionl nd Physicl Therpists Amy R. Drrgh, Wendy Huddleston, Phyllis King KEY WORDS ccidents, occuptionl moving nd lifting ptients musculoskeletl
More informationMental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes
Fmily Prctice, 2015, Vol. 32, No. 3, 317 322 doi:10.1093/fmpr/cmv014 Advnce Access publiction 5 April 2015 Helth Service Reserch Mentl helth symptoms nd ptient-reported dibetes symptom burden: implictions
More informationManagement and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence
Clinicin Summry Mentl Helth Eting Disorders Mngement nd Outcomes of Binge-Eting Disorder in Adults: Current Stte of the Evidence Focus of This Summry This is summry of systemtic review evluting the evidence
More informationIncreased Relative Mortality in Women With Severe Oxygen-Dependent COPD
CHEST Originl Reserch Incresed Reltive Mortlity in Women With Severe Oxygen-Dependent COPD Mgnus Ekström, MD ; Krl A. Frnklin, MD, PhD ; nd Kerstin E. Ström, MD, PhD COPD Bckground: Although the incidence
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationEmerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data
Emerging Options for Thromboprophylxis After Orthopedic Surgery: A Review of Clinicl Dt Bob L. Lobo, Phrm.D. In four rndomized, controlled studies of ptients undergoing orthopedic surgery, the ntithrombotic
More informationReview TEACHING FOR GENERALIZATION & MAINTENANCE
Gols By the end of clss, you should be ble to: Explin wht generliztion is, why it is criticl for techers to know how to tech so tht it occurs, nd give n exmple of it from your own experience in the clssroom
More informationUntil recently, only two drugs available for type 2. Weight Beneficial Treatments for Type 2 Diabetes
SPECIAL FEATURE Weight Beneficil Tretments for Type 2 Dietes Review L. F. Meneghini, D. Orozco-Beltrn, K. Khunti, S. Cputo, T. Dmçi, A. Liel, nd S. A. Ross Dietes Reserch Institute (L.F.M.), University
More informationDiabetes Care for Older Adults: Evidence based Strategies for Glycemic Treatment in Older Adults References
Dibetes Cre for Older Adults: Evidence bsed Strtegies for Glycemic Tretment in Older Adults Medh Munshi, MD Fridy, Februry 9, 2018 3:30p.m. 4:15 p.m. Older dults with dibetes re growing popultion with
More informationSoybean Hulls as an Alternative Feed for Horses
Animl Industry Report AS 650 ASL R1931 2004 Soyben Hulls s n Alterntive Feed for Horses Josie Booth Iow Stte University Howrd Tyler Iow Stte University Peggy Miller-Auwerd Iow Stte University Jenette Moore
More informationUS Food and Drug Administration-Mandated Trials of Long-Acting b -Agonists Safety in Asthma. Samy Suissa, PhD ; and Amnon Ariel, MD, FCCP
CHEST Commentry US Food nd Drug Administrtion-Mndted Trils of Long-Acting b -Agonists Sfety in Asthm Will We Know the Answer? Smy Suiss, PhD ; nd Amnon Ariel, MD, FCCP For 2 decdes, long-cting b -gonists
More informationSerum γ-glutamyltransferase: Independent Predictor of Risk of Diabetes, Hypertension, Metabolic Syndrome, and Coronary Disease
nture publishing group Serum γ-glutmyltrnsferse: Independent Predictor of Risk of Dibetes, Hypertension, Metbolic Syndrome, nd Coronry Disese Altn Ont 1, Güny Cn 2, Ender Örnek 3, Gökhn Çiçek 4, Erkn Ayhn
More informationOriginal Article Clinical Care/Education INTRODUCTION DIABETES & METABOLISM JOURNAL
Originl Article Clinicl Cre/Eduction https://doi.org/10.4093/dmj.2018.42.1.28 pissn 2233-6079 eissn 2233-6087 DIABETES & METABOLISM JOURNAL Improvement of Glycosylted Hemoglobin in Ptients with Type 2
More informationPotential for Interactions Between Dietary Supplements and Prescription Medications a
CLINICAL RESEARCH STUDY Potentil for Interctions Between Dietry Supplements nd Prescription Medictions Amit Sood, MD, MSc, Rich Sood, MD, b Frncis J. Brinker, ND, Rvneet Mnn, MBBS, c Lur L. Loehrer, Dietlind
More informationRisks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion
More informationBMI and Mortality: Results From a National Longitudinal Study of Canadian Adults
nture publishing group BMI nd Mortlity: Results From Ntionl Longitudinl Study of Cndin Adults Hether M. Orpn 1, Jen-Mrie Berthelot 2,3, Mrk S. Kpln 4, Dvid H. Feeny 5,6, Bentson McFrlnd 7 nd Nncy A. Ross
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationLongitudinal Association of Maternal Attempt to Lose Weight During the Postpartum Period and Child Obesity at Age 3 Years
nture publishing group Longitudinl Assocition of Mternl Attempt to Lose Weight During the Postprtum Period nd Child Obesity t Age 3 Yers Kendrin R. Sonneville 1,2, Sheryl L. Rifs-Shimn 3, Emily Oken 3,
More informationA Comparison of Serum Magnesium Level in Pregnant Women with and without Gestational Diabetes Mellitus (GDM)
Brief Report J Bbol Univ Med Sci Vol 18, Issu 12; Dec 2016. P:71-75 A Comprison of Serum Mgnesium Level in Pregnnt Women with nd without Gesttionl Dibetes Mellitus (GDM) Z. Bouzri (MD) 1, F. Elmi(MD) 2,
More informationThe Centers for Disease
originlcontributions Evluting the HIV Continuum of Cre within Lrge Integrted Helth System by Michel J. Willims, PhrmD nd Thoms J. Dilworth, PhrmD Abstrct Objective: The primry study objective ws to describe
More information